Health ❯ Healthcare ❯ Patient Safety

Drug Side Effects

Clinical Research Statin Side Effects Post-Marketing Surveillance Hospital Admissions Compensation Claims Pregnancy Outcomes Brain Swelling Acute Pancreatitis Gastrointestinal Issues Psychiatric Disorders

GLP‑1 Market Set to Balloon as Oral Pill Wins US Approval

US clearance of an oral GLP‑1 expands access while regulators and health systems confront supply strains, safety reports and care gaps.

Major Lancet Analysis Finds Most Statin Label Side Effects Not Caused by the Drugs

UK Regulator Adds Severe Pancreatitis Warning to Ozempic, Wegovy and Mounjaro

Denmark Awards Compensation to Four Patients for Eye Damage Linked to Ozempic and Wegovy

Novo Nordisk's Amycretin Shows 22% Weight Loss in Trial, Boosting Stock

Growing Demand for Weight-Loss Drugs in the UK Raises Safety and Accessibility Concerns